Emergence of Personalized Medications Fuels the Sector

Emergence of Personalized Medications Fuels the Sector
Company Logo
Company Logo

Global Pharmacy Automation Market

Global Pharmacy Automation Market
Global Pharmacy Automation Market

Dublin, April 19, 2023 (GLOBE NEWSWIRE) — The “Global Pharmacy Automation Market: Analysis by Product, End-user, Region, Size and Trends with Impact of COVID-19 and Forecast up to 2028” report has been added to ResearchAndMarkets.com’s offering.

The global pharmacy automation market was valued at US$5.90 billion and is expected to grow to US$9.76 billion by 2028. The term “Pharmacy Automation” refers to the use of technology and automated systems to improve the efficiency, accuracy, safety, and quality of pharmaceutical services.

Autonomous Pharmacy represents the shift in a pharmacies’ medication management approach from manual, headcount-based processes to a more automated and data-driven approach. This transition is supported by a combination of hardware, software, and tech enabled services.

Pharmacy Automation has now become the new norm for the pharmaceutical sector. When combined with Data Analytics, Machine Learning, and Artificial Intelligence systems, pharmacy automation devices are transforming the future of pharmacies.

Some of the reasons companies are switching to pharmacy automation are improved accuracy, increased efficiency, enhanced patient outcomes, improved workflow, and reduced cost, etc. The pharmacy automation market is projected to expand at a CAGR  over the forecast period of 2023-2028.

Global Pharmacy Automation Market Dynamics

Growth Drivers:

One of the most important factors impacting the pharmacy automation market dynamics is the rising patient safety concerns. Medication errors are a major cause of adverse drug events and can lead to harm or even death in patients. Pharmacy automation technologies can significantly reduce the risk of errors, as they are designed to improve accuracy and reduce the likelihood of human error.

Pharmacy automation can help to prevent medication-related complications and ensure that patients receive the appropriate care by ensuring that medications are dispensed in a timely manner and patients receive the correct dosages. Furthermore, the market has been growing over the past few years, due to factors such as aging population, increasing healthcare spending, rise of e-pharmacy, favorable government regulations, technological advancements, emergence of personalized medications, etc.

Challenges:

However, the market has been confronted with some challenges specifically, high implementation cost, and difficulty in incorporating with existing systems, etc.

Trends:

The market is projected to grow at a fast pace during the forecast period, due to various latest trends such as increasing adoption of robotic dispensing systems, growing demand for automated packaging and labelling systems, shift towards centralized Prescription filling, etc.

The pharmacy automation market is trending towards centralized prescription filling, which involves using a single location to fill prescriptions for multiple pharmacies, driven by the need for efficiency and cost savings. Centralization allows pharmacies to take advantage of advanced automation technologies, reduce waste, and better manage medication inventory.

Impact Analysis of COVID-19 and Way Forward

The COVID-19 pandemic forced the pharmaceutical industry to become more adaptive and receptive to change. The industry has started to rely on technology, creating a more patient-centric ecosystem, and implementing automation, digital, and analytical tools. These changes have made the industry more efficient, agile, and transparent, benefiting both the industry and patients.

The adoption of technology is expected to sustain even in the post-pandemic era, as pharmaceutical companies have realized the benefits of automation and digitization in streamlining operations, reducing costs, and minimizing errors. The pandemic has also changed the industry’s outlook towards technology, making it more receptive to new advancements, which will lead to further innovation and development.

Competitive Landscape

The global pharmacy automation market is fairly fragmented, with the presence of many players operating worldwide. The pharmacy automation market players mainly provide hardware/connected devices solutions.

The pharmacy automation sector is broadly categorized into two segments namely, the pharmacy automation devices vendors and the supply chain solutions players. Omnicell primarily operates within the pharmacy automation and supply chain management markets. Similar to Omnicell, a few of the connected device vendors also offer tech-enabled services to complement their automation devices offering.

The key players of the pharmacy automation market are:

  • Omnicell, Inc.
  • Becton, Dickinson and Company (Parata Systems)
  • Baxter International Inc.
  • KUKA (Swisslog Healthcare)
  • Capsa Healthcare
  • Oracle Cerner
  • Mckesson Corporation
  • Yuyama Co., Ltd
  • ARxIUM
  • Pearson Medical Technologies, LL
  • TouchPoint Medical
  • RxSafe

Key Attributes:

Report Attribute Details
No. of Pages 138
Forecast Period 2023 – 2028
Estimated Market Value (USD) in 2023 $6.37 Billion
Forecasted Market Value (USD) by 2028 $9.76 Billion
Compound Annual Growth Rate 8.9 Billion
Regions Covered Global

Key Topics Covered:

1. Executive Summary

2. Introduction

3. Global Market Analysis
3.1 Global Pharmacy Automation Market: An Analysis
3.1.1 Global Pharmacy Automation Market : An Overview
3.1.2 Global Pharmacy Automation Market by Value
3.1.3 Global Pharmacy Automation Market by Product (Automated Medication Dispensing Systems, Automated Storage & Retrieval Systems, Automated Packaging and Labelling Sytems, and Others)
3.1.4 Global Pharmacy Automation Market by End-User (Hospital Pharmacy, Retail Pharmacy, Clinical Pharmacy and Others)
3.1.5 Global Pharmacy Automation Market by Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)
3.2 Global Pharmacy Automation Market: Product Analysis
3.2.1 Global Pharmacy Automation Market by Product: An Overview
3.2.2 Global Automated Medication Dispensing System Market by Value
3.2.3 Global Automated Drug Storage & Retrieval Systems Market by Value
3.2.4 Global Automated Packaging & Labelling Systems Market by Value
3.2.5 Global Others Pharmacy Automation Market by Value
3.3 Global Pharmacy Automation Market: End-User Analysis
3.3.1 Global Pharmacy Automation Market by End-User : An Overview
3.3.2 Global Hospital Pharmacy Automation Market by Value
3.3.3 Global Retail Pharmacy Automation Market by Value
3.3.4 Global Clinical Pharmacy Automation Market by Value
3.3.5 Global Others Pharmacy Automation Market by Value

4. Regional Market Analysis

5. Impact of COVID-19
5.1 Impact of COVID-19 on Global Pharmacy Automation Market
5.2 Post COVID-19 Impact on Global Pharmacy Automation Market

6. Market Dynamics
6.1 Growth Drivers
6.1.1 Aging Population
6.1.2 Increasing Healthcare Spending
6.1.3 Rise of E-Pharmacy
6.1.4 Favorable Government Regulations
6.1.5 Technological Advancements
6.1.6 Rising Patient Safety Concerns
6.1.7 Emergence of Personalized Medications
6.2 Challenges
6.2.1 High Implementation Cost
6.2.2 Integration with Existing Systems
6.3 Market Trends
6.3.1 Increased Adoption of Robotic Dispensing
6.3.2 Growing Demand for Automated Packaging & Labelling Systems
6.3.3 Increasing Use of Data Analytics and Machine Learning
6.3.4 Shift towards Centralized Prescription Filling

7. Competitive Landscape
7.1 Global Pharmacy Automation Market Players: Competitive Landscape
7.2 Global Pharmacy Automation Market Players: Latest Offerings
7.3 Global Pharmacy Automation Market Players: Drug Dispensing Systems Comparison

8. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/6da7mg

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Mark Cuban’s Cost Plus Drugs could have saved his NBA team almost $150,000 on medications

Mark Cuban’s Cost Plus Drugs could have saved his NBA team almost 0,000 on medications

Almost a calendar year back, Mark Cuban, the billionaire proprietor of the Dallas Mavericks and superstar trader on ABC’s Shark Tank, introduced an on line pharmacy promising affordable costs on prescription drugs.

He kept to his assure.

Mark Cuban talked with moderator Emily Ramshaw, co-founder and CEO of The 19th News, in the course of the once-a-year Dallas Regional Chamber meeting Jan. 17, 2023, at the Winspear Opera Household in Dallas.

The Mark Cuban Expense Furthermore Drug Co. has simplified items for approximately 2 million consumers, Cuban told a packed crowd at the Dallas Regional Chamber’s 2023 once-a-year conference Tuesday. The only firm Cuban has ever put his identify on sells medications at a flat 15{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} markup, a $3 pharmacist cost and a $5 rate for shipping.

“Sometimes disruption is just about simplifying,” he reported. “The pharmaceutical business has just morphed into a extremely intricate sector.”

The business cuts out middlemen and negotiates straight with drug suppliers and pharmacies for rebates and bargains on behalf of businesses, health insurers and govt wellbeing programs. He stated Price As well as has by now signed discounts with a several unbiased pharmacies in Dallas and other metropolitan areas.

“It took out all the mystery of how medicines are priced,” Cuban mentioned.

It is a strategy that could help you save funds for even an NBA workforce like his Dallas Mavericks.

Mavs CEO Cynt Marshall compiled a list of the generic prescription drugs priced in excess of $30 that the crew acquired in 2021 and 2022. The workforce expended $165,000. If the staff had purchased by way of Value Furthermore, it would have price tag $19,000, Cuban stated.

He also pointed to the Harvard University report released in June that concluded Medicare could have saved $3.6 billion in a solitary yr if it experienced acquired generic drugs from the on the web pharmacy. And he talked about clients who go on his Twitter account to thank him for their personal personal savings.

Mark Cuban has Vegas-like vision for Dallas, new Mavs arena if Texas OKs on line casino gambling

Cuban’s entry into prescribed drugs commenced with an frequently-informed tale about a “cold email” he bought from Alex Oshmyansky seeking to commence a little compounding pharmacy. Which is exactly where Cuban figured out about the industry. Oshmyansky co-started the business with Cuban and is now its CEO.

Collectively, the two have been developing a 22,000-sq.-foot plant in Dallas’ Deep Ellum community to manufacture drugs. The facility is predicted to be done early this year.

Getting on major pharma would intimidate most other individuals. Cuban explained he does not consider there is any field that can not be disrupted. He traces his philosophy to his roots escalating up in Pittsburgh, a gritty metal city at the time which is due to the fact been reborn.

“I’ve just been a hustler my full life,” he said. “Whenever somebody advised me I couldn’t do anything, I think I obtained the most joy out of proving them improper. From that point on, it was often hoping to find a way to do items that other folks weren’t undertaking and do it initial. ”

Mark Cuban’s essential to results: ‘Somebody’s acquired to be the luckiest guy’